Association of N-Terminal Pro-Brain Natriuretic Peptide with Cognitive Function and Depression in Elderly People with Type 2 Diabetes
Type 2 diabetes mellitus is associated with risk of congestive heart failure (CHF), cognitive dysfunction and depression. CHF itself is linked both to poor cognition and depression. The ventricular N-terminal pro-brain natriuretic peptide (NT-proBNP) is a marker of CHF, suggesting potential as a mar...
Gespeichert in:
| Veröffentlicht in: | PloS one Jg. 7; H. 9; S. e44569 |
|---|---|
| Hauptverfasser: | , , , , , , |
| Format: | Journal Article |
| Sprache: | Englisch |
| Veröffentlicht: |
United States
Public Library of Science
04.09.2012
Public Library of Science (PLoS) |
| Schlagworte: | |
| ISSN: | 1932-6203, 1932-6203 |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| Abstract | Type 2 diabetes mellitus is associated with risk of congestive heart failure (CHF), cognitive dysfunction and depression. CHF itself is linked both to poor cognition and depression. The ventricular N-terminal pro-brain natriuretic peptide (NT-proBNP) is a marker of CHF, suggesting potential as a marker for cognitive impairment and/or depression. This was tested in the Edinburgh Type 2 Diabetes Study (ET2DS).
Cross-sectional analysis of 1066 men and women aged 60-75 with type 2 diabetes. Results from seven neuropsychological tests were combined in a standardised general cognitive ability factor, 'g'. A vocabulary-based test estimated pre-morbid cognitive ability. The Hospital Anxiety and Depression Scale (HADS) assessed possible depression. After adjustment for age and sex, raised plasma NT-proBNP was weakly associated with lower 'g' and higher depression scores (ß -0.09, 95% CI -0.13 to -0.03, p = 0.004 and ß 0.08, 95% CI 0.04 to 0.12, p<0.001, respectively). Comparing extreme quintiles of NT-proBNP, subjects in the highest quintile were more likely to have reduced cognitive ability (within the lowest tertile of 'g') and 'possible' depression (HADS depression ≥8) (OR 1.80; 95% CI: 1.20, 2.70; p = 0.005 and OR 2.18; 95% CI: 1.28, 3.71; p = 0.004, respectively). Associations persisted when pre-morbid ability was adjusted for, but as expected were no longer statistically significant following the adjustment for diabetes-related and vascular co-variates (β -0.02, 95% CI -0.07 to 0.03, p>0.05 for 'g'; β 0.03, 95% CI -0.02 to 0.07, p>0.05 for depression scores).
Raised plasma NT-proBNP was weakly but statistically significantly associated with poorer cognitive function and depression. The prospective phases of the ET2DS will help determine whether or not NT-proBNP can be considered a risk marker for subsequent cognitive impairment and incident depression and whether it provides additional information over and above traditional risk factors for these conditions. |
|---|---|
| AbstractList | Background Type 2 diabetes mellitus is associated with risk of congestive heart failure (CHF), cognitive dysfunction and depression. CHF itself is linked both to poor cognition and depression. The ventricular N-terminal pro-brain natriuretic peptide (NT-proBNP) is a marker of CHF, suggesting potential as a marker for cognitive impairment and/or depression. This was tested in the Edinburgh Type 2 Diabetes Study (ET2DS). Methodology and Principal Findings Cross-sectional analysis of 1066 men and women aged 60-75 with type 2 diabetes. Results from seven neuropsychological tests were combined in a standardised general cognitive ability factor, 'g'. A vocabulary-based test estimated pre-morbid cognitive ability. The Hospital Anxiety and Depression Scale (HADS) assessed possible depression. After adjustment for age and sex, raised plasma NT-proBNP was weakly associated with lower 'g' and higher depression scores (ß -0.09, 95% CI -0.13 to -0.03, p = 0.004 and ß 0.08, 95% CI 0.04 to 0.12, p0.05 for 'g'; [beta] 0.03, 95% CI -0.02 to 0.07, p>0.05 for depression scores). Conclusion Raised plasma NT-proBNP was weakly but statistically significantly associated with poorer cognitive function and depression. The prospective phases of the ET2DS will help determine whether or not NT-proBNP can be considered a risk marker for subsequent cognitive impairment and incident depression and whether it provides additional information over and above traditional risk factors for these conditions. Type 2 diabetes mellitus is associated with risk of congestive heart failure (CHF), cognitive dysfunction and depression. CHF itself is linked both to poor cognition and depression. The ventricular N-terminal pro-brain natriuretic peptide (NT-proBNP) is a marker of CHF, suggesting potential as a marker for cognitive impairment and/or depression. This was tested in the Edinburgh Type 2 Diabetes Study (ET2DS). Cross-sectional analysis of 1066 men and women aged 60-75 with type 2 diabetes. Results from seven neuropsychological tests were combined in a standardised general cognitive ability factor, 'g'. A vocabulary-based test estimated pre-morbid cognitive ability. The Hospital Anxiety and Depression Scale (HADS) assessed possible depression. After adjustment for age and sex, raised plasma NT-proBNP was weakly associated with lower 'g' and higher depression scores (ß -0.09, 95% CI -0.13 to -0.03, p = 0.004 and ß 0.08, 95% CI 0.04 to 0.12, p<0.001, respectively). Comparing extreme quintiles of NT-proBNP, subjects in the highest quintile were more likely to have reduced cognitive ability (within the lowest tertile of 'g') and 'possible' depression (HADS depression ≥8) (OR 1.80; 95% CI: 1.20, 2.70; p = 0.005 and OR 2.18; 95% CI: 1.28, 3.71; p = 0.004, respectively). Associations persisted when pre-morbid ability was adjusted for, but as expected were no longer statistically significant following the adjustment for diabetes-related and vascular co-variates (β -0.02, 95% CI -0.07 to 0.03, p>0.05 for 'g'; β 0.03, 95% CI -0.02 to 0.07, p>0.05 for depression scores). Raised plasma NT-proBNP was weakly but statistically significantly associated with poorer cognitive function and depression. The prospective phases of the ET2DS will help determine whether or not NT-proBNP can be considered a risk marker for subsequent cognitive impairment and incident depression and whether it provides additional information over and above traditional risk factors for these conditions. BackgroundType 2 diabetes mellitus is associated with risk of congestive heart failure (CHF), cognitive dysfunction and depression. CHF itself is linked both to poor cognition and depression. The ventricular N-terminal pro-brain natriuretic peptide (NT-proBNP) is a marker of CHF, suggesting potential as a marker for cognitive impairment and/or depression. This was tested in the Edinburgh Type 2 Diabetes Study (ET2DS).Methodology and principal findingsCross-sectional analysis of 1066 men and women aged 60-75 with type 2 diabetes. Results from seven neuropsychological tests were combined in a standardised general cognitive ability factor, 'g'. A vocabulary-based test estimated pre-morbid cognitive ability. The Hospital Anxiety and Depression Scale (HADS) assessed possible depression. After adjustment for age and sex, raised plasma NT-proBNP was weakly associated with lower 'g' and higher depression scores (ß -0.09, 95% CI -0.13 to -0.03, p = 0.004 and ß 0.08, 95% CI 0.04 to 0.12, p<0.001, respectively). Comparing extreme quintiles of NT-proBNP, subjects in the highest quintile were more likely to have reduced cognitive ability (within the lowest tertile of 'g') and 'possible' depression (HADS depression ≥8) (OR 1.80; 95% CI: 1.20, 2.70; p = 0.005 and OR 2.18; 95% CI: 1.28, 3.71; p = 0.004, respectively). Associations persisted when pre-morbid ability was adjusted for, but as expected were no longer statistically significant following the adjustment for diabetes-related and vascular co-variates (β -0.02, 95% CI -0.07 to 0.03, p>0.05 for 'g'; β 0.03, 95% CI -0.02 to 0.07, p>0.05 for depression scores).ConclusionRaised plasma NT-proBNP was weakly but statistically significantly associated with poorer cognitive function and depression. The prospective phases of the ET2DS will help determine whether or not NT-proBNP can be considered a risk marker for subsequent cognitive impairment and incident depression and whether it provides additional information over and above traditional risk factors for these conditions. Background Type 2 diabetes mellitus is associated with risk of congestive heart failure (CHF), cognitive dysfunction and depression. CHF itself is linked both to poor cognition and depression. The ventricular N-terminal pro-brain natriuretic peptide (NT-proBNP) is a marker of CHF, suggesting potential as a marker for cognitive impairment and/or depression. This was tested in the Edinburgh Type 2 Diabetes Study (ET2DS). Methodology and Principal Findings Cross-sectional analysis of 1066 men and women aged 60–75 with type 2 diabetes. Results from seven neuropsychological tests were combined in a standardised general cognitive ability factor, ‘g’. A vocabulary-based test estimated pre-morbid cognitive ability. The Hospital Anxiety and Depression Scale (HADS) assessed possible depression. After adjustment for age and sex, raised plasma NT-proBNP was weakly associated with lower ‘g’ and higher depression scores (β −0.09, 95% CI −0.13 to −0.03, p = 0.004 and β 0.08, 95% CI 0.04 to 0.12, p<0.001, respectively). Comparing extreme quintiles of NT-proBNP, subjects in the highest quintile were more likely to have reduced cognitive ability (within the lowest tertile of ‘g’) and ‘possible’ depression (HADS depression ≥8) (OR 1.80; 95% CI: 1.20, 2.70; p = 0.005 and OR 2.18; 95% CI: 1.28, 3.71; p = 0.004, respectively). Associations persisted when pre-morbid ability was adjusted for, but as expected were no longer statistically significant following the adjustment for diabetes-related and vascular co-variates (β −0.02, 95% CI −0.07 to 0.03, p>0.05 for ‘g’; β 0.03, 95% CI −0.02 to 0.07, p>0.05 for depression scores). Conclusion Raised plasma NT-proBNP was weakly but statistically significantly associated with poorer cognitive function and depression. The prospective phases of the ET2DS will help determine whether or not NT-proBNP can be considered a risk marker for subsequent cognitive impairment and incident depression and whether it provides additional information over and above traditional risk factors for these conditions. Type 2 diabetes mellitus is associated with risk of congestive heart failure (CHF), cognitive dysfunction and depression. CHF itself is linked both to poor cognition and depression. The ventricular N-terminal pro-brain natriuretic peptide (NT-proBNP) is a marker of CHF, suggesting potential as a marker for cognitive impairment and/or depression. This was tested in the Edinburgh Type 2 Diabetes Study (ET2DS). Cross-sectional analysis of 1066 men and women aged 60-75 with type 2 diabetes. Results from seven neuropsychological tests were combined in a standardised general cognitive ability factor, 'g'. A vocabulary-based test estimated pre-morbid cognitive ability. The Hospital Anxiety and Depression Scale (HADS) assessed possible depression. After adjustment for age and sex, raised plasma NT-proBNP was weakly associated with lower 'g' and higher depression scores (ß -0.09, 95% CI -0.13 to -0.03, p = 0.004 and ß 0.08, 95% CI 0.04 to 0.12, p0.05 for 'g'; [beta] 0.03, 95% CI -0.02 to 0.07, p>0.05 for depression scores). Raised plasma NT-proBNP was weakly but statistically significantly associated with poorer cognitive function and depression. The prospective phases of the ET2DS will help determine whether or not NT-proBNP can be considered a risk marker for subsequent cognitive impairment and incident depression and whether it provides additional information over and above traditional risk factors for these conditions. Type 2 diabetes mellitus is associated with risk of congestive heart failure (CHF), cognitive dysfunction and depression. CHF itself is linked both to poor cognition and depression. The ventricular N-terminal pro-brain natriuretic peptide (NT-proBNP) is a marker of CHF, suggesting potential as a marker for cognitive impairment and/or depression. This was tested in the Edinburgh Type 2 Diabetes Study (ET2DS).BACKGROUNDType 2 diabetes mellitus is associated with risk of congestive heart failure (CHF), cognitive dysfunction and depression. CHF itself is linked both to poor cognition and depression. The ventricular N-terminal pro-brain natriuretic peptide (NT-proBNP) is a marker of CHF, suggesting potential as a marker for cognitive impairment and/or depression. This was tested in the Edinburgh Type 2 Diabetes Study (ET2DS).Cross-sectional analysis of 1066 men and women aged 60-75 with type 2 diabetes. Results from seven neuropsychological tests were combined in a standardised general cognitive ability factor, 'g'. A vocabulary-based test estimated pre-morbid cognitive ability. The Hospital Anxiety and Depression Scale (HADS) assessed possible depression. After adjustment for age and sex, raised plasma NT-proBNP was weakly associated with lower 'g' and higher depression scores (ß -0.09, 95% CI -0.13 to -0.03, p = 0.004 and ß 0.08, 95% CI 0.04 to 0.12, p<0.001, respectively). Comparing extreme quintiles of NT-proBNP, subjects in the highest quintile were more likely to have reduced cognitive ability (within the lowest tertile of 'g') and 'possible' depression (HADS depression ≥8) (OR 1.80; 95% CI: 1.20, 2.70; p = 0.005 and OR 2.18; 95% CI: 1.28, 3.71; p = 0.004, respectively). Associations persisted when pre-morbid ability was adjusted for, but as expected were no longer statistically significant following the adjustment for diabetes-related and vascular co-variates (β -0.02, 95% CI -0.07 to 0.03, p>0.05 for 'g'; β 0.03, 95% CI -0.02 to 0.07, p>0.05 for depression scores).METHODOLOGY AND PRINCIPAL FINDINGSCross-sectional analysis of 1066 men and women aged 60-75 with type 2 diabetes. Results from seven neuropsychological tests were combined in a standardised general cognitive ability factor, 'g'. A vocabulary-based test estimated pre-morbid cognitive ability. The Hospital Anxiety and Depression Scale (HADS) assessed possible depression. After adjustment for age and sex, raised plasma NT-proBNP was weakly associated with lower 'g' and higher depression scores (ß -0.09, 95% CI -0.13 to -0.03, p = 0.004 and ß 0.08, 95% CI 0.04 to 0.12, p<0.001, respectively). Comparing extreme quintiles of NT-proBNP, subjects in the highest quintile were more likely to have reduced cognitive ability (within the lowest tertile of 'g') and 'possible' depression (HADS depression ≥8) (OR 1.80; 95% CI: 1.20, 2.70; p = 0.005 and OR 2.18; 95% CI: 1.28, 3.71; p = 0.004, respectively). Associations persisted when pre-morbid ability was adjusted for, but as expected were no longer statistically significant following the adjustment for diabetes-related and vascular co-variates (β -0.02, 95% CI -0.07 to 0.03, p>0.05 for 'g'; β 0.03, 95% CI -0.02 to 0.07, p>0.05 for depression scores).Raised plasma NT-proBNP was weakly but statistically significantly associated with poorer cognitive function and depression. The prospective phases of the ET2DS will help determine whether or not NT-proBNP can be considered a risk marker for subsequent cognitive impairment and incident depression and whether it provides additional information over and above traditional risk factors for these conditions.CONCLUSIONRaised plasma NT-proBNP was weakly but statistically significantly associated with poorer cognitive function and depression. The prospective phases of the ET2DS will help determine whether or not NT-proBNP can be considered a risk marker for subsequent cognitive impairment and incident depression and whether it provides additional information over and above traditional risk factors for these conditions. Background Type 2 diabetes mellitus is associated with risk of congestive heart failure (CHF), cognitive dysfunction and depression. CHF itself is linked both to poor cognition and depression. The ventricular N-terminal pro-brain natriuretic peptide (NT-proBNP) is a marker of CHF, suggesting potential as a marker for cognitive impairment and/or depression. This was tested in the Edinburgh Type 2 Diabetes Study (ET2DS). Methodology and Principal Findings Cross-sectional analysis of 1066 men and women aged 60–75 with type 2 diabetes. Results from seven neuropsychological tests were combined in a standardised general cognitive ability factor, ‘g’. A vocabulary-based test estimated pre-morbid cognitive ability. The Hospital Anxiety and Depression Scale (HADS) assessed possible depression. After adjustment for age and sex, raised plasma NT-proBNP was weakly associated with lower ‘g’ and higher depression scores (β −0.09, 95% CI −0.13 to −0.03, p = 0.004 and β 0.08, 95% CI 0.04 to 0.12, p<0.001, respectively). Comparing extreme quintiles of NT-proBNP, subjects in the highest quintile were more likely to have reduced cognitive ability (within the lowest tertile of ‘g’) and ‘possible’ depression (HADS depression ≥8) (OR 1.80; 95% CI: 1.20, 2.70; p = 0.005 and OR 2.18; 95% CI: 1.28, 3.71; p = 0.004, respectively). Associations persisted when pre-morbid ability was adjusted for, but as expected were no longer statistically significant following the adjustment for diabetes-related and vascular co-variates (β −0.02, 95% CI −0.07 to 0.03, p>0.05 for ‘g’; β 0.03, 95% CI −0.02 to 0.07, p>0.05 for depression scores). Conclusion Raised plasma NT-proBNP was weakly but statistically significantly associated with poorer cognitive function and depression. The prospective phases of the ET2DS will help determine whether or not NT-proBNP can be considered a risk marker for subsequent cognitive impairment and incident depression and whether it provides additional information over and above traditional risk factors for these conditions. |
| Audience | Academic |
| Author | Price, Jackie F. Welsh, Paul Strachan, Mark W. J. Reynolds, Rebecca M. Deary, Ian J. Sattar, Naveed Feinkohl, Insa |
| AuthorAffiliation | German Diabetes Center, Leibniz Center for Diabetes Research at Heinrich Heine University Duesseldorf, Germany |
| AuthorAffiliation_xml | – name: German Diabetes Center, Leibniz Center for Diabetes Research at Heinrich Heine University Duesseldorf, Germany |
| Author_xml | – sequence: 1 givenname: Insa surname: Feinkohl fullname: Feinkohl, Insa – sequence: 2 givenname: Naveed surname: Sattar fullname: Sattar, Naveed – sequence: 3 givenname: Paul surname: Welsh fullname: Welsh, Paul – sequence: 4 givenname: Rebecca M. surname: Reynolds fullname: Reynolds, Rebecca M. – sequence: 5 givenname: Ian J. surname: Deary fullname: Deary, Ian J. – sequence: 6 givenname: Mark W. J. surname: Strachan fullname: Strachan, Mark W. J. – sequence: 7 givenname: Jackie F. surname: Price fullname: Price, Jackie F. |
| BackLink | https://www.ncbi.nlm.nih.gov/pubmed/22973461$$D View this record in MEDLINE/PubMed |
| BookMark | eNqNk11v0zAUhiM0xD7gHyCIhITgosWJHTfmAqnsAypN2wSDW8txjltXbhxsZ9AfwP_GaTO0ThNCkWL75HnfEx-dc5jsNbaBJHmeoXGGJ9m7pe1cI8y4jeExQoQUlD1KDjKG8xHNEd67s99PDr1fIlTgktInyX6eswkmNDtIfk-9t1KLoG2TWpVejK7BrXQ0Tq-cHX10QjfphQhOdw6ClukVtEHXkP7UYZEe23mjg76B9Kxr5MZDNHV6Aq0D7_tjVJ-aGpxZR6VtzSC8XreQ5umJFhUE8E-Tx0oYD8-G9Sj5dnZ6ffx5dH75aXY8PR9JyvIwIjlgyGoi6mKiKkWVJHSC4zsv8aSsSsZKXJSVrEiFGCogLhVlNa1LqlDBED5KXm59W2M9HyroeYZzWhCKSBmJ2ZaorVjy1umVcGtuheabgHVzLlysgwGeK4nqsgYFQpC4r6hSAgiTTMaErIpeH4ZsXbWCWkITnDA7prtfGr3gc3vDMcGY5CwavBkMnP3RgQ98pb0EY0QDtov_nZGsyBHJevTVPfTh2w3UXMQL6EbZmFf2pnxaxKSITljvNX6Aik8NKy1juykd4zuCtzuCyAT4Feai857Pvn75f_by-y77-g67AGHCwlvT9Y3md8EXdyv9t8S3fR6B91tAOuu9A8WlDpumj1fThmeI90N1WzTeDxUfhiqKyT3xrf8_ZX8AJzInaQ |
| CitedBy_id | crossref_primary_10_1007_s00592_019_01295_9 crossref_primary_10_4103_0366_6999_200536 crossref_primary_10_1111_jgs_16092 crossref_primary_10_1136_gpsych_2024_101596 crossref_primary_10_1159_000499671 crossref_primary_10_1007_s00125_014_3375_9 crossref_primary_10_1097_PSY_0000000000000289 crossref_primary_10_1161_ATVBAHA_118_311082 crossref_primary_10_1016_j_archger_2024_105413 crossref_primary_10_1007_s12020_014_0323_x crossref_primary_10_1038_s41598_017_15394_6 crossref_primary_10_1186_1744_9081_9_34 crossref_primary_10_1016_j_jalz_2016_09_004 crossref_primary_10_1097_CM9_0000000000000260 crossref_primary_10_1136_jnnp_2014_309968 crossref_primary_10_3233_JAD_160328 crossref_primary_10_1016_j_cellsig_2017_11_004 crossref_primary_10_1093_jnen_nlad060 crossref_primary_10_1212_WNL_0000000000001885 crossref_primary_10_1002_ana_24203 crossref_primary_10_1212_WNL_0000000000000820 |
| ContentType | Journal Article |
| Copyright | COPYRIGHT 2012 Public Library of Science Feinkohl et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License: https://creativecommons.org/licenses/by/4.0/ (the “License”), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. 2012 Feinkohl et al 2012 Feinkohl et al |
| Copyright_xml | – notice: COPYRIGHT 2012 Public Library of Science – notice: Feinkohl et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License: https://creativecommons.org/licenses/by/4.0/ (the “License”), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. – notice: 2012 Feinkohl et al 2012 Feinkohl et al |
| CorporateAuthor | on behalf of the Edinburgh Type 2 Diabetes Study (ET2DS) Investigators Edinburgh Type 2 Diabetes Study-ET2DS Investigators |
| CorporateAuthor_xml | – name: on behalf of the Edinburgh Type 2 Diabetes Study (ET2DS) Investigators – name: Edinburgh Type 2 Diabetes Study-ET2DS Investigators |
| DBID | AAYXX CITATION CGR CUY CVF ECM EIF NPM IOV ISR 3V. 7QG 7QL 7QO 7RV 7SN 7SS 7T5 7TG 7TM 7U9 7X2 7X7 7XB 88E 8AO 8C1 8FD 8FE 8FG 8FH 8FI 8FJ 8FK ABJCF ABUWG AEUYN AFKRA ARAPS ATCPS AZQEC BBNVY BENPR BGLVJ BHPHI C1K CCPQU D1I DWQXO FR3 FYUFA GHDGH GNUQQ H94 HCIFZ K9. KB. KB0 KL. L6V LK8 M0K M0S M1P M7N M7P M7S NAPCQ P5Z P62 P64 PATMY PDBOC PHGZM PHGZT PIMPY PJZUB PKEHL PPXIY PQEST PQGLB PQQKQ PQUKI PRINS PTHSS PYCSY RC3 7X8 5PM DOA |
| DOI | 10.1371/journal.pone.0044569 |
| DatabaseName | CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed Opposing Viewpoints Gale In Context: Science ProQuest Central (Corporate) Animal Behavior Abstracts Bacteriology Abstracts (Microbiology B) Biotechnology Research Abstracts Nursing & Allied Health Database Ecology Abstracts Entomology Abstracts (Full archive) Immunology Abstracts Meteorological & Geoastrophysical Abstracts Nucleic Acids Abstracts Virology and AIDS Abstracts Agricultural Science Collection Health & Medical Collection ProQuest Central (purchase pre-March 2016) Medical Database (Alumni Edition) ProQuest Pharma Collection Public Health Database Technology Research Database ProQuest SciTech Collection ProQuest Technology Collection ProQuest Natural Science Journals Hospital Premium Collection Hospital Premium Collection (Alumni Edition) ProQuest Central (Alumni) (purchase pre-March 2016) Materials Science & Engineering Collection ProQuest Central (Alumni) One Sustainability ProQuest Central UK/Ireland Advanced Technologies & Computer Science Collection Agricultural & Environmental Science Collection ProQuest Central Essentials - QC Biological Science Collection ProQuest Central Technology Collection Natural Science Collection Environmental Sciences and Pollution Management ProQuest One Community College ProQuest Materials Science Collection ProQuest Central Engineering Research Database Proquest Health Research Premium Collection Health Research Premium Collection (Alumni) ProQuest Central Student AIDS and Cancer Research Abstracts SciTech Premium Collection ProQuest Health & Medical Complete (Alumni) Materials Science Database Nursing & Allied Health Database (Alumni Edition) Meteorological & Geoastrophysical Abstracts - Academic ProQuest Engineering Collection Biological Sciences Agriculture Science Database ProQuest Health & Medical Collection Medical Database Algology Mycology and Protozoology Abstracts (Microbiology C) Biological Science Database Engineering Database Nursing & Allied Health Premium Advanced Technologies & Aerospace Database ProQuest Advanced Technologies & Aerospace Collection Biotechnology and BioEngineering Abstracts Environmental Science Database Materials Science Collection ProQuest Central Premium ProQuest One Academic (New) Publicly Available Content Database ProQuest Health & Medical Research Collection ProQuest One Academic Middle East (New) ProQuest One Health & Nursing ProQuest One Academic Eastern Edition (DO NOT USE) ProQuest One Applied & Life Sciences ProQuest One Academic (retired) ProQuest One Academic UKI Edition ProQuest Central China Engineering Collection Environmental Science Collection Genetics Abstracts MEDLINE - Academic PubMed Central (Full Participant titles) DOAJ Directory of Open Access Journals |
| DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) Agricultural Science Database Publicly Available Content Database ProQuest Central Student ProQuest Advanced Technologies & Aerospace Collection ProQuest Central Essentials Nucleic Acids Abstracts SciTech Premium Collection ProQuest Central China Environmental Sciences and Pollution Management ProQuest One Applied & Life Sciences ProQuest One Sustainability Health Research Premium Collection Meteorological & Geoastrophysical Abstracts Natural Science Collection Health & Medical Research Collection Biological Science Collection ProQuest Central (New) ProQuest Medical Library (Alumni) Engineering Collection Advanced Technologies & Aerospace Collection Engineering Database Virology and AIDS Abstracts ProQuest Biological Science Collection ProQuest One Academic Eastern Edition Agricultural Science Collection ProQuest Hospital Collection ProQuest Technology Collection Health Research Premium Collection (Alumni) Biological Science Database Ecology Abstracts ProQuest Hospital Collection (Alumni) Biotechnology and BioEngineering Abstracts Environmental Science Collection Entomology Abstracts Nursing & Allied Health Premium ProQuest Health & Medical Complete ProQuest One Academic UKI Edition Environmental Science Database ProQuest Nursing & Allied Health Source (Alumni) Engineering Research Database ProQuest One Academic Meteorological & Geoastrophysical Abstracts - Academic ProQuest One Academic (New) Technology Collection Technology Research Database ProQuest One Academic Middle East (New) Materials Science Collection ProQuest Health & Medical Complete (Alumni) ProQuest Central (Alumni Edition) ProQuest One Community College ProQuest One Health & Nursing ProQuest Natural Science Collection ProQuest Pharma Collection ProQuest Central ProQuest Health & Medical Research Collection Genetics Abstracts ProQuest Engineering Collection Biotechnology Research Abstracts Health and Medicine Complete (Alumni Edition) ProQuest Central Korea Bacteriology Abstracts (Microbiology B) Algology Mycology and Protozoology Abstracts (Microbiology C) Agricultural & Environmental Science Collection AIDS and Cancer Research Abstracts Materials Science Database ProQuest Materials Science Collection ProQuest Public Health ProQuest Nursing & Allied Health Source ProQuest SciTech Collection Advanced Technologies & Aerospace Database ProQuest Medical Library Animal Behavior Abstracts Materials Science & Engineering Collection Immunology Abstracts ProQuest Central (Alumni) MEDLINE - Academic |
| DatabaseTitleList | MEDLINE MEDLINE - Academic Agricultural Science Database |
| Database_xml | – sequence: 1 dbid: DOA name: DOAJ Directory of Open Access Journals url: https://www.doaj.org/ sourceTypes: Open Website – sequence: 2 dbid: NPM name: PubMed url: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 3 dbid: PIMPY name: Publicly Available Content Database url: http://search.proquest.com/publiccontent sourceTypes: Aggregation Database |
| DeliveryMethod | fulltext_linktorsrc |
| Discipline | Sciences (General) Medicine |
| DocumentTitleAlternate | NT-proBNP Associations with Cognition/Depression |
| EISSN | 1932-6203 |
| ExternalDocumentID | 1326546048 oai_doaj_org_article_2fc0d8defeaa4fc0b6ffae49c9cd869b PMC3433429 2943644031 A543306799 22973461 10_1371_journal_pone_0044569 |
| Genre | Research Support, Non-U.S. Gov't Journal Article |
| GeographicLocations | United Kingdom--UK Scotland Edinburgh Scotland |
| GeographicLocations_xml | – name: United Kingdom--UK – name: Edinburgh Scotland – name: Scotland |
| GrantInformation_xml | – fundername: Chief Scientist Office grantid: CZG/2/478 – fundername: British Heart Foundation grantid: FS/10/005/28147 – fundername: Medical Research Council grantid: G0500877 – fundername: Chief Scientist Office grantid: CZB/4/582 |
| GroupedDBID | --- 123 29O 2WC 53G 5VS 7RV 7X2 7X7 7XC 88E 8AO 8C1 8CJ 8FE 8FG 8FH 8FI 8FJ A8Z AAFWJ AAUCC AAWOE AAYXX ABDBF ABIVO ABJCF ABUWG ACCTH ACGFO ACIHN ACIWK ACPRK ACUHS ADBBV ADRAZ AEAQA AENEX AEUYN AFFHD AFKRA AFPKN AFRAH AHMBA ALMA_UNASSIGNED_HOLDINGS AOIJS APEBS ARAPS ATCPS BAWUL BBNVY BCNDV BENPR BGLVJ BHPHI BKEYQ BPHCQ BVXVI BWKFM CCPQU CITATION CS3 D1I D1J D1K DIK DU5 E3Z EAP EAS EBD EMOBN ESX EX3 F5P FPL FYUFA GROUPED_DOAJ GX1 HCIFZ HH5 HMCUK HYE IAO IEA IGS IHR IHW INH INR IOV IPNFZ IPY ISE ISR ITC K6- KB. KQ8 L6V LK5 LK8 M0K M1P M48 M7P M7R M7S M~E NAPCQ O5R O5S OK1 OVT P2P P62 PATMY PDBOC PHGZM PHGZT PIMPY PJZUB PPXIY PQGLB PQQKQ PROAC PSQYO PTHSS PYCSY RIG RNS RPM SV3 TR2 UKHRP WOQ WOW ~02 ~KM BAIFH BBTPI CGR CUY CVF ECM EIF ESTFP NPM PV9 RZL ALIPV BBORY 3V. 7QG 7QL 7QO 7SN 7SS 7T5 7TG 7TM 7U9 7XB 8FD 8FK AZQEC C1K DWQXO FR3 GNUQQ H94 K9. KL. M7N P64 PKEHL PQEST PQUKI PRINS RC3 7X8 PUEGO 5PM AAPBV ABPTK BBAFP N95 |
| ID | FETCH-LOGICAL-c692t-42e3e1d4ad57fbf6fc4673fc428378b8998358bcb4b0905e4b0b69d6d86f05903 |
| IEDL.DBID | M7P |
| ISICitedReferencesCount | 22 |
| ISICitedReferencesURI | http://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=Summon&SrcAuth=ProQuest&DestLinkType=CitingArticles&DestApp=WOS_CPL&KeyUT=000308577600069&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D |
| ISSN | 1932-6203 |
| IngestDate | Sun Nov 06 00:11:22 EDT 2022 Mon Nov 10 04:25:22 EST 2025 Tue Nov 04 02:02:16 EST 2025 Sat Sep 27 22:04:22 EDT 2025 Sat Nov 29 14:24:57 EST 2025 Sat Nov 29 13:15:20 EST 2025 Sat Nov 29 10:01:44 EST 2025 Wed Nov 26 10:12:33 EST 2025 Wed Nov 26 10:10:23 EST 2025 Thu May 22 21:19:51 EDT 2025 Mon Nov 17 00:33:45 EST 2025 Sat Nov 29 03:58:07 EST 2025 Tue Nov 18 22:17:28 EST 2025 |
| IsDoiOpenAccess | true |
| IsOpenAccess | true |
| IsPeerReviewed | true |
| IsScholarly | true |
| Issue | 9 |
| Language | English |
| License | This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are properly credited. Creative Commons Attribution License |
| LinkModel | DirectLink |
| MergedId | FETCHMERGED-LOGICAL-c692t-42e3e1d4ad57fbf6fc4673fc428378b8998358bcb4b0905e4b0b69d6d86f05903 |
| Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 content type line 23 Competing Interests: The ET2DS is co-funded by Pfizer plc. This does not alter the authors' adherence to all the PLoS ONE policies on sharing data and materials. Conceived and designed the experiments: JFP MWJS. Performed the experiments: IJD NS PW RMR. Analyzed the data: IF. Wrote the paper: IF NS PW RMR IJD MWJS JFP. |
| OpenAccessLink | https://www.proquest.com/docview/1326546048?pq-origsite=%requestingapplication% |
| PMID | 22973461 |
| PQID | 1326546048 |
| PQPubID | 1436336 |
| PageCount | e44569 |
| ParticipantIDs | plos_journals_1326546048 doaj_primary_oai_doaj_org_article_2fc0d8defeaa4fc0b6ffae49c9cd869b pubmedcentral_primary_oai_pubmedcentral_nih_gov_3433429 proquest_miscellaneous_1141520419 proquest_journals_1326546048 gale_infotracmisc_A543306799 gale_infotracacademiconefile_A543306799 gale_incontextgauss_ISR_A543306799 gale_incontextgauss_IOV_A543306799 gale_healthsolutions_A543306799 pubmed_primary_22973461 crossref_citationtrail_10_1371_journal_pone_0044569 crossref_primary_10_1371_journal_pone_0044569 |
| PublicationCentury | 2000 |
| PublicationDate | 2012-09-04 |
| PublicationDateYYYYMMDD | 2012-09-04 |
| PublicationDate_xml | – month: 09 year: 2012 text: 2012-09-04 day: 04 |
| PublicationDecade | 2010 |
| PublicationPlace | United States |
| PublicationPlace_xml | – name: United States – name: San Francisco – name: San Francisco, USA |
| PublicationTitle | PloS one |
| PublicationTitleAlternate | PLoS One |
| PublicationYear | 2012 |
| Publisher | Public Library of Science Public Library of Science (PLoS) |
| Publisher_xml | – name: Public Library of Science – name: Public Library of Science (PLoS) |
| SSID | ssj0053866 |
| Score | 2.1968408 |
| Snippet | Type 2 diabetes mellitus is associated with risk of congestive heart failure (CHF), cognitive dysfunction and depression. CHF itself is linked both to poor... Background Type 2 diabetes mellitus is associated with risk of congestive heart failure (CHF), cognitive dysfunction and depression. CHF itself is linked both... BackgroundType 2 diabetes mellitus is associated with risk of congestive heart failure (CHF), cognitive dysfunction and depression. CHF itself is linked both... Background Type 2 diabetes mellitus is associated with risk of congestive heart failure (CHF), cognitive dysfunction and depression. CHF itself is linked both... |
| SourceID | plos doaj pubmedcentral proquest gale pubmed crossref |
| SourceType | Open Website Open Access Repository Aggregation Database Index Database Enrichment Source |
| StartPage | e44569 |
| SubjectTerms | Aged Analysis Ankle Anxiety Atherosclerosis Blood Pressure Body Mass Index Brain Brain natriuretic peptide Brain research Cardiovascular disease Cholesterol - blood Cognition Cognition & reasoning Cognition - physiology Cognitive ability Cognitive disorders Congestive heart failure Cross-Sectional Studies Dementia Depression (Mood disorder) Depression - complications Depression - metabolism Diabetes Diabetes mellitus Diabetes mellitus (non-insulin dependent) Diabetes Mellitus, Type 2 - complications Ethics Female Geriatrics Health risks Heart failure Heart Failure - complications Heart Failure - metabolism Hospitals Humans Impairment Intelligence Male Medicine Memory Mental depression Middle Aged Natriuretic Peptide, Brain - blood Natriuretic peptides Neuropsychological Tests Older people Peptide Fragments - blood Peptides Psychological aspects Risk analysis Risk factors Statistical analysis Systematic review Type 2 diabetes Ventricle |
| SummonAdditionalLinks | – databaseName: DOAJ Directory of Open Access Journals dbid: DOA link: http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1Lb9QwELbQqgcuiLZAFwoYhAQc0ubhOPGxVFQgoQXxqHqL_IRKq2TV7CLxA_jfzNhOtEGVyoE97Ebx2MnOjMfjZOYbQl7AeQMfmZS2gA2KtDyRmVKJ4FqCg8Ft7cu3nX-oFov64kJ82ir1hTFhAR44MO44dzo1tbHOSsngWHHnpGVCC21qLhRaX_B6hs1UsMEwizmPiXJFlR1HuRytutYe4TvMEgOctxYij9c_WuXZatn117mcf0dObi1FZ3fJnehD0pNw77vklm33yG6cpT19FaGkX--T31vcp52jiyQGvywpXDVRWB-CtojSv_HZjHSFQS7GUnw8S8fQIoqrnx9DtoaOwbMthd4Wy3wvf9EQih464nNdmtPhue498u3s7dfTd0ksvJBoLvJ1wnJb2MwwacrKKcedBnNawDdC5dQKt2hFWSutmEpFWlr4UVwYDgJxmMxa3CezFlh9QCgHSlOXSmROsczlymapNIiAw5hjms1JMUih0RGVHItjLBv_qq2C3UlgaoOya6Ls5iQZe60CKscN9G9QwCMtYmr7E6BpTdS05iZNm5OnqB5NSFAdLUNzUrICN14CLvPcUyCuRouBO9_lpu-b9x_P_4Hoy-cJ0ctI5Dpgh5YxWQL-E-J1TSgPJ5RgHfSk-QCVeeBKDzzKMX8NDDf0HBT8-uZnYzMOisF4re02PSayg9eXsgxGfxDmw8jZHGuhMZ7NSTWZKRPWT1vayx8e1ryAewbv6OH_kNUjchs829wHA7JDMltfbexjsqN_ri_7qyfeVvwB93B2qw priority: 102 providerName: Directory of Open Access Journals – databaseName: Public Library of Science (PLoS) Journals Open Access dbid: FPL link: http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlR1db9Mw0ILCAy_A-FphgEFIwENGPhw3ftzGKpCmUsGY9hb5EyZVSdW0SPwA_jd3jhOWaRPQh7SK7xzn7Dvf1fdByCu4b-Ajo9xmYKBIyyOZKBUJriUoGNwWvnzbydFkNitOT8X8j6F44QQ_myTvAk13l3Vld_H8MefiOrmRZpyjC9d0ftRJXuBdzkN43FWYg-3HZ-nvZfFouaibyxTNi_6S5zag6Z3_HfpdcjuomnSvXRtb5Jqt7pGtwMwNfRMyTr-9T36dmyRaOzqLjlsfmQWdr-poH8tI0Bkm89_4oEc6R18YYyn-i0sPOg8kOoVN0vchK0Pfdz62FQXsQ6wGvvgJmOix3iKiDUxTGpxymgfk6_Tw-OBDFOozRJqLdB2x1GY2MUyafOKU406D1M3gihl1CoWWXJYXSiumYhHnFr4UF4abgjuMec0eklEFpNkmlAOkKXIlEqdY4lJlk1gaTJTDmGOajUnWTVupQ_JyrKGxKP2J3ASMmJaoJdK6DLQek6jHWrbJO_4Cv48roofF1Nv-BkxqGTi5TJ2OTWGss1Iy-K24c9IyoYWGFxNqTJ7jeirbONZegJR7OcvQPhPwmJceAtNvVOjf801umqb8-OnkH4C-fB4AvQ5ArgZyaBliKuCdMK3XAHJnAAlCRA-at3H1d1RpgEYphrmBfAfMjiMub37RN2On6LNX2XrTYLw7KIcxS6D3Ry0D9ZRNsWQa48mYTAasNSD9sKU6--6zn2cwZlCiHl894ifkFqi1qfcEZDtktF5t7FNyU_9YnzWrZ15k_Ab1v25r priority: 102 providerName: Public Library of Science |
| Title | Association of N-Terminal Pro-Brain Natriuretic Peptide with Cognitive Function and Depression in Elderly People with Type 2 Diabetes |
| URI | https://www.ncbi.nlm.nih.gov/pubmed/22973461 https://www.proquest.com/docview/1326546048 https://www.proquest.com/docview/1141520419 https://pubmed.ncbi.nlm.nih.gov/PMC3433429 https://doaj.org/article/2fc0d8defeaa4fc0b6ffae49c9cd869b http://dx.doi.org/10.1371/journal.pone.0044569 |
| Volume | 7 |
| WOSCitedRecordID | wos000308577600069&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| journalDatabaseRights | – providerCode: PRVAON databaseName: DOAJ Directory of Open Access Journals customDbUrl: eissn: 1932-6203 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0053866 issn: 1932-6203 databaseCode: DOA dateStart: 20060101 isFulltext: true titleUrlDefault: https://www.doaj.org/ providerName: Directory of Open Access Journals – providerCode: PRVHPJ databaseName: ROAD: Directory of Open Access Scholarly Resources customDbUrl: eissn: 1932-6203 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0053866 issn: 1932-6203 databaseCode: M~E dateStart: 20060101 isFulltext: true titleUrlDefault: https://road.issn.org providerName: ISSN International Centre – providerCode: PRVPQU databaseName: Advanced Technologies & Aerospace Database customDbUrl: eissn: 1932-6203 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0053866 issn: 1932-6203 databaseCode: P5Z dateStart: 20061201 isFulltext: true titleUrlDefault: https://search.proquest.com/hightechjournals providerName: ProQuest – providerCode: PRVPQU databaseName: Agricultural Science Database customDbUrl: eissn: 1932-6203 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0053866 issn: 1932-6203 databaseCode: M0K dateStart: 20061201 isFulltext: true titleUrlDefault: https://search.proquest.com/agriculturejournals providerName: ProQuest – providerCode: PRVPQU databaseName: Biological Science Database customDbUrl: eissn: 1932-6203 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0053866 issn: 1932-6203 databaseCode: M7P dateStart: 20061201 isFulltext: true titleUrlDefault: http://search.proquest.com/biologicalscijournals providerName: ProQuest – providerCode: PRVPQU databaseName: Engineering Database customDbUrl: eissn: 1932-6203 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0053866 issn: 1932-6203 databaseCode: M7S dateStart: 20061201 isFulltext: true titleUrlDefault: http://search.proquest.com providerName: ProQuest – providerCode: PRVPQU databaseName: Environmental Science Database customDbUrl: eissn: 1932-6203 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0053866 issn: 1932-6203 databaseCode: PATMY dateStart: 20061201 isFulltext: true titleUrlDefault: http://search.proquest.com/environmentalscience providerName: ProQuest – providerCode: PRVPQU databaseName: Health & Medical Collection customDbUrl: eissn: 1932-6203 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0053866 issn: 1932-6203 databaseCode: 7X7 dateStart: 20061201 isFulltext: true titleUrlDefault: https://search.proquest.com/healthcomplete providerName: ProQuest – providerCode: PRVPQU databaseName: Materials Science Database customDbUrl: eissn: 1932-6203 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0053866 issn: 1932-6203 databaseCode: KB. dateStart: 20061201 isFulltext: true titleUrlDefault: http://search.proquest.com/materialsscijournals providerName: ProQuest – providerCode: PRVPQU databaseName: Nursing & Allied Health Database customDbUrl: eissn: 1932-6203 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0053866 issn: 1932-6203 databaseCode: 7RV dateStart: 20061201 isFulltext: true titleUrlDefault: https://search.proquest.com/nahs providerName: ProQuest – providerCode: PRVPQU databaseName: ProQuest Central customDbUrl: eissn: 1932-6203 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0053866 issn: 1932-6203 databaseCode: BENPR dateStart: 20061201 isFulltext: true titleUrlDefault: https://www.proquest.com/central providerName: ProQuest – providerCode: PRVPQU databaseName: Public Health Database customDbUrl: eissn: 1932-6203 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0053866 issn: 1932-6203 databaseCode: 8C1 dateStart: 20061201 isFulltext: true titleUrlDefault: https://search.proquest.com/publichealth providerName: ProQuest – providerCode: PRVPQU databaseName: Publicly Available Content Database customDbUrl: eissn: 1932-6203 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0053866 issn: 1932-6203 databaseCode: PIMPY dateStart: 20061201 isFulltext: true titleUrlDefault: http://search.proquest.com/publiccontent providerName: ProQuest – providerCode: PRVATS databaseName: Public Library of Science (PLoS) Journals Open Access customDbUrl: eissn: 1932-6203 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0053866 issn: 1932-6203 databaseCode: FPL dateStart: 20060101 isFulltext: true titleUrlDefault: http://www.plos.org/publications/ providerName: Public Library of Science |
| link | http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV3db9MwELfYxgMvwPhaYRSDkICHdE3iOMkTWkcrpm0l6kZVeIlixx6TqqQ0KxJ_AP83d45TFjQBEn24VvHZjT_u_PW7O0JewvMcPpkTKB82KJniTuYK4cRcZrDA4Coy4dumx-F4HM1mcWIP3CoLq2x0olHUeSnxjHwPdk1odwMD7u3iq4NRo_B21YbQ2CBb6CXBN9C9pNHEIMucW3M5P3T3bO_0FmWheniTGSDM-cp0ZLz2r3Xz5mJeVtctPH_HT16ZkEZ3_rcqd8ltuxSl-_XY2SY3VHGPbFthr-hr65H6zX3y40on0lLTsXNWY2jmNFmWzgDDTNAxOvtfGaNImiBWJlcUT3npQYNQoiOYRE0ZWZHTdw0Gt6CQe4jRwuffISci2uuMuEemHrWgneoB-Tganh28d2z8Bkfy2Lt0mKd85eYsy4NQC821BK3sA0WPO5HAnZ4fREIKJvpxP1DwJXic8zziGm1i_Ydks4C-2iGUA2ceBSJ2tWCu9oRy-1mOjnQY00yyDvGbbkyldW6OMTbmqbmxC2GTUzdqip2f2s7vEGeda1E79_gL_wBHyJoXXXObB-XyPLWSnnpa9vMoV1plGYPfgmudKRbLWELFYtEhz3B8pbWd61rBpPsB83H_FsPfvDAc6J6jQPzPebaqqvTww_QfmE4nLaZXlkmX0BwyszYXUCd0-9Xi3G1xgpKRreQdlIamVar01xiGnM0ovz75-ToZC0VMX6HKVYX28LB47DMXSn9UC9S6ZT0Mqca42yFhS9RaTd9OKS6-GO_oPrwzLLIe__m1npBbsPT1DFqQ7ZLNy-VKPSU35bfLi2rZJRvhZIp0FhoaAY0O3C7ZGgzHyaRrTm6AjpJjoEeDHtCT_lHXqB9DT4EmwWfIkRyeJJ9-AsK3jKo |
| linkProvider | ProQuest |
| linkToHtml | http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMw1V1Lb9NAEF6VgAQXoLwaKHRBIODgNrbXG_uAUF9Ro4ZQlRD1ZryvUimyQ5yA-gP4O_xGZuy1iVEFXHoghyTyzm7syczs7O43M4Q8h-sKXokTaB8WKInmTuIK4URcJuBgcB0W5dvGg-5wGJ6cREcr5EcVC4OwysomFoZaZRL3yLdg1YRxNyBwb6dfHKwahaerVQmNUiwO9fk3WLLlb_p78P--8Lze_mj3wLFVBRzJI2_uME_72lUsUUHXCMONBFvhwzvmgQkFrj_8IBRSMNGJOoGGD8EjxVXIDUZq-jDuFXIV7LiLELLu8biy_GA7OLfheX7X3bLSsDnNUr2JJ6cBwqqXpr-iSkA9F7Smkyy_yNH9Ha-5NAH2bv1vrLtNblpXm26XurFKVnR6h6xaY5bTVzbj9uu75PuSkNLM0KEzKjFCE3o0y5wdLKNBh1jMYFEEfdIjxAIpTXEXm-5WCCzaAyehGCNJFd2rMMYphd77WA19cg49EbFfdsQ9AOpRC0rK75GPl8KO-6SVgmysEcqBUoWBiFwjmGs8od1OojBREGOGSdYmfiU2sbTJ27GGyCQuTiS7sIgrmRqjsMVW2NrEqXtNy-Qlf6HfQYmsaTH1eHEhm53G1pLFnpEdFSptdJIw-C64MYlmkYwkPFgk2mQD5Tku43hrAxpvB8zH9WkEP_OsoMD0Iynim06TRZ7H_ffjfyD6cNwgemmJTAbskImNKYFnwrRmDcr1BiUYUdloXkPtq7iSx790BnpWWnVx89O6GQdFzGKqs0WO8f7gHHeYC6M_KBW45qyHJeMYd9uk21DtBuubLenZ5yL7uw_3DMbn4Z9va4NcPxi9G8SD_vDwEbkBbr5XICPZOmnNZwv9mFyTX-dn-exJYcIo-XTZiv8TLRPcng |
| linkToPdf | http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMw1V3NbtNAEF6VgBAXoPw1UOiCQMDBbWyv1_YBoTZpRNUqRNBWvRnvX6kU2SFOQH0AXoqnY8ZemxhVwKUHckgi7-zGnszMzu5-M0PIc7iu4JU6gfZhgZJq7qSuEE7MZQoOBtdRWb7t-CAcjaKTk3i8Qn7UsTAIq6xtYmmoVS5xj3wLVk0Yd4NpZo2FRYwHw7fTLw5WkMKT1rqcRiUi-_r8Gyzfijd7A_ivX3jecPew_86xFQYcyWNv7jBP-9pVLFVBaIThRoLd8OEdc8JEAtcifhAJKZjoxb1Aw4fgseIq4gajNn0Y9wq5GvogxRil3m_gJWBHOLehen7oblnJ2Jzmmd7EU9QAIdZLU2FZMaCZFzrTSV5c5PT-jt1cmgyHt_5nNt4mN60LTrcrnVklKzq7Q1atkSvoK5uJ-_Vd8n1JeGlu6Mg5rLBDEzqe5c4OltegIyxysCiDQekYMUJKU9zdpv0amUWH4DyUY6SZooMae5xR6L2LVdIn59ATkfxVR9wboB61YKXiHjm6FHbcJ50M5GSNUA6UKgpE7BrBXOMJ7fZShQmEGDNMsi7xaxFKpE3qjrVFJkl5UhnC4q5iaoKCl1jB6xKn6TWtkpr8hX4HpbOhxZTk5YV8dppYC5d4RvZUpLTRacrgu-DGpJrFMpbwYLHokg2U7aSK720Ma7IdMB_XrTH8zLOSAtOSZCiZp-miKJK998f_QPTxQ4vopSUyObBDpjbWBJ4J0521KNdblGBcZat5DTWx5kqR_NIf6Flr2MXNT5tmHBSxjJnOFwXmAQCnucdcGP1BpcwNZz0sJce42yVhS81brG-3ZGefy6zwPtwzOJcP_3xbG-Q66HtysDfaf0RugPfvlYBJtk4689lCPybX5Nf5WTF7UlozSj5dtt7_BOZ45Pk |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Association+of+N-Terminal+Pro-Brain+Natriuretic+Peptide+with+Cognitive+Function+and+Depression+in+Elderly+People+with+Type+2+Diabetes&rft.jtitle=PloS+one&rft.au=Feinkohl%2C+Insa&rft.au=Sattar%2C+Naveed&rft.au=Price%2C+Jackie+F&rft.au=Deary%2C+Ian+J&rft.date=2012-09-04&rft.pub=Public+Library+of+Science&rft.issn=1932-6203&rft.eissn=1932-6203&rft.volume=7&rft.issue=9&rft.spage=e44569&rft_id=info:doi/10.1371%2Fjournal.pone.0044569&rft.externalDBID=n%2Fa&rft.externalDocID=A543306799 |
| thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1932-6203&client=summon |
| thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1932-6203&client=summon |
| thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1932-6203&client=summon |